Larsson, Henrik

Suicide Immediately After Discharge From Psychiatric Inpatient Care: A Cohort Study of Nearly 2.9 Million Discharges

Haglund, A., Lysell, H., Larsson, H., Lichtenstein, P., & Runeson, B. (2019) · The Journal of Clinical Psychiatry

Suicide and Self-Harm StudiesPsychiatric care and mental health services

Cited by 66

Methylphenidate and the risk of psychosis in adolescents and young adults: a population-based cohort study

Hollis, C., Chen, Q., Chang, Z., Quinn, P. D., Viktorin, A., Lichtenstein, P., D'Onofrio, B., Landén, M., & Larsson, H. (2019) · The Lancet Psychiatry

Attention Deficit Hyperactivity DisorderSchizophrenia research and treatment

Cited by 65

The familial aggregation of atopic diseases and depression or anxiety in children

Brew, B. K., Lundholm, C., Gong, T., Larsson, H., & Almqvist, C. (2018) · Clinical & Experimental Allergy

Asthma and respiratory diseasesChild and Adolescent Psychosocial and Emotional Development

Cited by 62

Population-based, multi-generational family clustering study of social anxiety disorder and avoidant personality disorder

Isomura, K., Boman, M., Rück, C., Serlachius, E., Larsson, H., Lichtenstein, P., & Mataix-Cols, D. (2015) · Psychological Medicine

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesChild and Adolescent Psychosocial and Emotional Development

Cited by 61

Medications for Alcohol and Opioid Use Disorders and Risk of Suicidal Behavior, Accidental Overdoses, and Crime

Molero, Y., Zetterqvist, J., Binswanger, I. A., Hellner, C., Larsson, H., & Fazel, S. (2018) · American Journal of Psychiatry

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 60

Sex-specific manifestation of genetic risk for attention deficit hyperactivity disorder in the general population

Martin, J., Taylor, M. J., Rydell, M., Riglin, L., Eyre, O., Lu, Y., Lundström, S., Larsson, H., Thapar, A., & Lichtenstein, P. (2018) · Journal of Child Psychology and Psychiatry

Attention Deficit Hyperactivity DisorderGenetic Associations and Epidemiology

Cited by 57

Research Review: The strength of the genetic overlap between ADHD and other psychiatric symptoms – a systematic review and meta‐analysis

Andersson, A., Tuvblad, C., Chen, Q., Du Rietz, E., Cortese, S., Kuja‐Halkola, R., & Larsson, H. (2020) · Journal of Child Psychology and Psychiatry

Attention Deficit Hyperactivity DisorderGenetic Associations and Epidemiology

Cited by 56

Attention-deficit/hyperactivity disorder is associated with increased risk of cardiovascular diseases: a systematic review and meta-analysis

Li, L., Yao, H., Zhang, L., Garcia‐Argibay, M., Du Rietz, E., Brikell, I., Solmi, M., Cortese, S., Ramos‐Quiroga, J. A., Ribasés, M., et al. (2023) · JCPP Advances

Attention Deficit Hyperactivity DisorderCardiovascular Health and Risk Factors

Cited by 55

An Epidemiological Study of ADHD, Substance Use, and Comorbid Problems in Incarcerated Women in Sweden

Konstenius, M., Larsson, H., Lundholm, L., Philips, B., van de Glind, G., Jayaram-Lindström, N., & Franck, J. (2015) · Journal of Attention Disorders

Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and Outcomes

Cited by 54

The association between type 2 diabetes and attention- deficit/hyperactivity disorder: a systematic review, meta-analysis, and population-based sibling study

Garcia-Argibay, M., Li, L., Du Rietz, E., Zhang, L., Yao, H., Jendle, J., Ramos-Quiroga, J. A., Ribasés, M., Chang, Z., Brikell, I., et al. (2023) · Neuroscience & Biobehavioral Reviews

Attention Deficit Hyperactivity DisorderDiabetes Management and Research

Cited by 52

The association between Darier disease, bipolar disorder, and schizophrenia revisited: a population-based family study

Cederlöf, M., Bergen, S. E., Långström, N., Larsson, H., Boman, M., Craddock, N., Östberg, P., Lundström, S., Sjölander, A., Nordlind, K., et al. (2015) · Bipolar Disorders

Bipolar Disorder and TreatmentSchizophrenia research and treatment

Cited by 52

Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder

Demontis, D., Walters, R. K., Rajagopal, V. M., Waldman, I. D., Grove, J., Als, T. D., Dalsgaard, S., Ribasés, M., Bybjerg-Grauholm, J., Bækvad-Hansen, M., et al. (2021) · Nature Communications

Attention Deficit Hyperactivity DisorderGenetic Associations and Epidemiology

Cited by 50

Early-life antibiotic use and risk of attention-deficit hyperactivity disorder and autism spectrum disorder: results of a discordant twin study

Slob, E. M. A., Brew, B. K., Vijverberg, S. J. H., Dijs, T., van Beijsterveldt, C. E. M., Koppelman, G. H., Bartels, M., Dolan, C. V., Larsson, H., Lundström, S., et al. (2021) · International Journal of Epidemiology

Gut microbiota and healthAutism Spectrum Disorder Research

Cited by 43

A population-based family clustering study of tic-related obsessive-compulsive disorder

Brander, G., Kuja-Halkola, R., Rosenqvist, M. A., Rück, C., Serlachius, E., Fernández de la Cruz, L., Lichtenstein, P., Crowley, J. J., Larsson, H., & Mataix-Cols, D. (2021) · Molecular Psychiatry

Obsessive-Compulsive Spectrum DisordersPsychoanalysis and Psychopathology Research

Cited by 39

Trajectories of healthcare utilization and costs of psychiatric and somatic multimorbidity in adults with childhood ADHD: a prospective register-based study

Du Rietz, E., Jangmo, A., Kuja‐Halkola, R., Chang, Z., D'Onofrio, B. M., Ahnemark, E., Werner‐Kiechle, T., & Larsson, H. (2020) · Journal of Child Psychology and Psychiatry

Attention Deficit Hyperactivity DisorderChronic Disease Management Strategies

Cited by 39

Association of opioid prescription initiation during adolescence and young adulthood with subsequent substance-related morbidity

Quinn, P. D., Fine, K. L., Rickert, M. E., Sujan, A. C., Boersma, K., Chang, Z., Franck, J., Lichtenstein, P., Larsson, H., & D’Onofrio, B. M. (2020) · JAMA Pediatrics

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 38

Antidiabetics, statins and the risk of amyotrophic lateral sclerosis

Mariosa, D., Kamel, F., Bellocco, R., Ronnevi, L. ‐., Almqvist, C., Larsson, H., Ye, W., & Fang, F. (2020) · European Journal of Neurology

Amyotrophic Lateral Sclerosis ResearchLipoproteins and Cardiovascular Health

Cited by 38

Maternal Effects as Causes of Risk for Obsessive-Compulsive Disorder

Mahjani, B., Klei, L., Hultman, C. M., Larsson, H., Devlin, B., Buxbaum, J. D., Sandin, S., & Grice, D. E. (2020) · Biological Psychiatry

Obsessive-Compulsive Spectrum DisordersGenetic Associations and Epidemiology

Cited by 36

The management of sleep disturbances in children with attention-deficit/hyperactivity disorder (ADHD): an update of the literature

Cortese, S., Fusetto Veronesi, G., Gabellone, A., Margari, A., Marzulli, L., Matera, E., Petruzelli, M. G., Piarulli, F. M., Tarantino, F., Bellato, A., et al. (2024) · Expert Review of Neurotherapeutics

Sleep and related disordersAttention Deficit Hyperactivity Disorder

Cited by 34

Attention-deficit/hyperactivity disorder and major depressive disorder: evidence from multiple genetically informed designs

Garcia-Argibay, M., Brikell, I., Thapar, A., Lichtenstein, P., Lundström, S., Demontis, D., & Larsson, H. (2024) · Biological Psychiatry

Attention Deficit Hyperactivity DisorderGenetic Associations and Epidemiology

Cited by 33

Evaluating ADHD medication trial representativeness: a Swedish population-based study comparing hypothetically trial-eligible and trial-ineligible individuals

Garcia-Argibay, M., Chang, Z., Brikell, I., Kuja-Halkola, R., D'Onofrio, B. M., Lichtenstein, P., Newcorn, J. H., Faraone, S. V., Larsson, H., & Cortese, S. (2025) · The Lancet Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 31

Methylphenidate and short-term cardiovascular risk

Garcia-Argibay, M., Bürkner, P.-C., Lichtenstein, P., Zhang, L., D’Onofrio, B. M., Andell, P., Chang, Z., Cortese, S., & Larsson, H. (2024) · JAMA Network Open

Attention Deficit Hyperactivity DisorderPharmacovigilance and Adverse Drug Reactions

Cited by 31

Prevalence of sleep disorder diagnoses and sleep medication prescriptions in individuals with ADHD across the lifespan: a Swedish nationwide register-based study

Ahlberg, R., Garcia-Argibay, M., Taylor, M., Lichtenstein, P., D'Onofrio, B. M., Butwicka, A., Hill, C., Cortese, S., Larsson, H., & Du Rietz, E. (2023) · BMJ Mental Health

Attention Deficit Hyperactivity DisorderSleep and related disorders

Cited by 29

Real-life instability in ADHD from young to middle adulthood: a nationwide register-based study of social and occupational problems

Ahlberg, R., Du Rietz, E., Ahnemark, E., Andersson, L. M., Werner-Kiechle, T., Lichtenstein, P., Larsson, H., & Garcia-Argibay, M. (2023) · BMC Psychiatry

Attention Deficit Hyperactivity DisorderAutism Spectrum Disorder Research

Cited by 27